E-LIB Suche - Ergebnisse für: Sallman, David

1

Hypomethylating Agents and Venetoclax for Acute Myeloid Leu..:

Ionescu, Filip ; David, Jerel C. ; Ravichandran, Apoorva...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 6 - p. 400-406 , 2024

Link: https://doi.org/10.1016/..

2

Outcomes of acute myeloid leukemia patients who responded t..:

Garciaz, Sylvain ; Dumas, Pierre‐Yves ; Bertoli, Sarah...
American Journal of Hematology. , 2024

Link: https://doi.org/10.1002/..

3

Incidence of pleural effusion with dasatinib and the effect..:

Jain, Akriti G ; Gesiotto, Quinto ; Ball, Somedeb...
Annals of Hematology. 103 (2024) 6 - p. 1941-1945 , 2024

Link: https://doi.org/10.1007/..

4

Triple-Negative Myelofibrosis: Disease Features, Response t..:

Aguirre, Luis E. ; Jain, Akriti ; Ball, Somedeb...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 7 - p. 459-467 , 2024

Link: https://doi.org/10.1016/..

5

Patterns of lower risk myelodysplastic syndrome progression..:

Jain, Akriti G. ; Ball, Somedeb ; Aguirre, Luis...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

6

Real-world Effectiveness of Azacitidine in Treatment-Naive ..:

Rajakumaraswamy, Nishanthan ; Gandhi, Mitul ; Wei, Andrew H....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 4 - p. 260-268.e2 , 2024

Link: https://doi.org/10.1016/..

7

Final phase I substudy results of ivosidenib in patients wi..:

DiNardo, Courtney D. D ; Roboz, Gail J. ; Watts, Justin M...
Blood Advances. , 2024

Link: https://doi.org/10.1182/..

8

Toward a more patient‐centered drug development process in ..:

Efficace, Fabio ; Buckstein, Rena ; Abel, Gregory A....
HemaSphere. 8 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

9

Mutations highly specific for secondary AML are associated ..:

Chan, Onyee ; Al Ali, Najla ; Tashkandi, Hammad...
Blood Advances. 8 (2024) 5 - p. 1075-1083 , 2024

Link: https://doi.org/10.1182/..

10

Venetoclax and hypomethylating agents in octogenarians and ..:

Madarang, Ellen ; Lykon, Jillian ; Zhao, Wei...
Blood Neoplasia. 1 (2024) 2 - p. 100016 , 2024

Link: https://doi.org/10.1016/..

11

POSTER: MDS-641 Randomized Phase 1-2 Study to Assess Safety..:

Garcia-Manero, Guillermo ; Bachiashvili, Kimo ; Griffiths, Elizabeth A....
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S187 , 2023

Link: https://doi.org/10.1016/..

12

Phase I Trial of CD8-Depleted Human Leukocyte Antigen (HLA)..:

Elmariah, Hany ; Kim, Jongphil ; Reid, Kayla...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S204-S205 , 2023

Link: https://doi.org/10.1016/..

13

TP53 variant allele frequency and therapy‐related setting i..:

Tefferi, Ayalew ; Fleti, Farah ; Chan, Onyee...
British Journal of Haematology. 204 (2023) 4 - p. 1243-1248 , 2023

Link: https://doi.org/10.1111/..

14

MDS-358 Activity of Luspatercept and ESAs Combination for T..:

Al Ali, Najla ; Luis, Aguirre ; Onyee, Chan...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S363-S364 , 2023

Link: https://doi.org/10.1016/..

15

POSTER: AML-554 A Phase III, Randomized, Open-Label Study E..:

Daver, Naval G. ; Vyas, Paresh ; Xing, Guan...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S171 , 2023

Link: https://doi.org/10.1016/..